Drugplain

BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE 325 mg/1

BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE · CAPSULE · Amneal Pharmaceuticals of New York, LLC

No Recall History
Plain English

BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE is a capsule containing butalbital, aspirin, caffeine and codeine phosphate at 325 mg/1, taken oral. Manufactured by Amneal Pharmaceuticals of New York, LLC.

Key Facts

Brand Name
BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE
Generic Name
BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE
NDC Code (Product)
69238-1993
Manufacturer
Amneal Pharmaceuticals of New York, LLC
Strength
325 mg/1
Dosage Form
CAPSULE
Route
ORAL
Marketing Status
DEA Schedule
Schedule III (Controlled)
Application #
ANDA074951
Drug Class
Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]
Marketing Start
04/01/2019

Recall History

No Recall History

Frequently Asked Questions

What is BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE used for?

BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE contains BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE. It is a capsule taken oral. Consult your doctor for specific uses.

Is BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE a controlled substance?

Yes, BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE is classified as CIII under the DEA Controlled Substances Act.

What is the generic name for BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE?

The generic name for BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE is BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE. There are 2 other brand versions of BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE.

What is the NDC code for BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE 325 mg/1?

The NDC (National Drug Code) for BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE 325 mg/1 is 69238-1993, listed by Amneal Pharmaceuticals of New York, LLC.

Product NDC

69238-1993

Package NDC

69238-1993-1

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)